A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

Status:
Terminated

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects ages 18 and older with generalized anxiety disorder.

Phase 3

Pfizer

Paroxetine